DEVELOPMENT OF RAMOSETRON HYDROCHLORIDE TRANSDERMAL DELIVERY SYSTEM FOR CHEMOTHERAPY INDUCED NAUSEA AND VOMITING
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: PP, Naseef (JAMIA SALAFIYA PHARMACY COLLEGE, PHARMACEUTICS, KALIKAVU, India)
- Co-author(s): Naseef P P
Nausea and Vomiting are very common after chemotherapy. Ramosetron HCl is a 5HT3 antagonist. Patient non-compliance can be successfully rectified by modification of the conventional dosage form to TDDS.
Formulations were done using different polymers such as EC, HPMC, PVA, SCMC and PVP in different ratios and combinations. Dibutyl phthalate and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.